-
-
7 . Academic Journal
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
- 저자
- by Kargbo, M; Bockarie, E; James, N L; Kabbah, A; Kamara, A, et al.
- 소스
- In The Lancet Infectious Diseases January 2022 22(1):97-109